Analyst Research Report Snapshot

Title:

CARMAT - BRAVEHEART

Price:

$10.00

Provider:

Edison Investment Research

Date:

17 Jun 2013

Pages:

2

Type:

AcrobatPDF

Companies referenced:

ALCAR.PA

Available for Immediate Download
Summary:

Carmat is due to implant its artificial heart in humans at four international cardiac centres. The data will be used for CE mark submission. The next steps are to start the patient selection process and to complete the training of cardiac surgeons. Carmat aims to address the significant shortfall in donor hearts.

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.